MR1-dependent MAIT cell activation is regulated by autophagy-associated proteins
The antigen-presenting molecule, MR1, presents microbial metabolites to MAIT cells, a population of innate-like, antimicrobial T cells. It also presents an unidentified ligand to MR1-restricted T cells in the setting of cancer. The cellular cofactors that regulate MR1 antigen presentation have yet to be fully defined. We performed a mass spectrometry–based proteomics screen to identify MR1-interacting proteins and discovered the selective autophagy receptor SQSTM1/p62. CRISPR-Cas9-mediated knockout of SQSTM1/p62 increased MAIT cell activation in the presence of Escherichia coli but not the synthetic ligand 5-OP-RU, whereas depletion of Atg5 and Atg7, key autophagy proteins, increased MAIT activation irrespective of the ligand used. This regulation appears to occur at an early step in the MR1 trafficking pathway. These data implicate distinct roles for autophagy-associated proteins in the regulation of MR1 activity and highlight the contribution of the autophagy pathway to regulation of cellular antigen presentation.
Authors
- Emanuele Marchi (ORCID: https://orcid.org/0000-0003-1741-9353)
- Carl-Philipp Hackstein (ORCID: https://orcid.org/0000-0002-0821-5204)
- Paul Klenerman (ORCID: https://orcid.org/0000-0003-4307-9161)
- Prabhjeet K. Phalora (ORCID: https://orcid.org/0000-0001-9614-0216)
- Jeffrey Y. W. Mak (ORCID: https://orcid.org/0000-0002-8011-4539)
- David P. Fairlie (ORCID: https://orcid.org/0000-0002-7856-8566)
- Svenja Hester (ORCID: https://orcid.org/0000-0003-2420-9063)
- James E. Ussher (ORCID: https://orcid.org/0000-0001-9222-7680)
Institutions
- The University of Queensland (AU)
- University of Oxford (GB)
- Medawar Building for Pathogen Research (GB)
- Institute for Molecular Bioscience (AU)
- University of Otago (NZ)
Publication Details
- Journal
- Life Science Alliance
- Published
- 2026-11-19
- DOI
- https://doi.org/10.26508/lsa.202603914
- Citations
- 1
- Primary Topic
- T-cell and B-cell Immunology
- Type
- article
- Field-Weighted Citation Impact
- 1.66
Funders
- Wellcome Trust
- University of Oxford
- National Institutes of Health
- Medical Research Council
- National Health and Medical Research Council
- National Institute of Allergy and Infectious Diseases